1. Home
  2. RBBN vs FHTX Comparison

RBBN vs FHTX Comparison

Compare RBBN & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.12

Market Cap

355.8M

Sector

Technology

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$6.14

Market Cap

360.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
FHTX
Founded
1997
2015
Country
United States
United States
Employees
N/A
106
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
360.5M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
RBBN
FHTX
Price
$2.12
$6.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$4.67
$11.50
AVG Volume (30 Days)
807.6K
213.2K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
25.32
EPS
N/A
N/A
Revenue
N/A
$30,909,000.00
Revenue This Year
$1.97
$8.89
Revenue Next Year
$6.69
$20.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
36.75
52 Week Low
$1.83
$3.27
52 Week High
$4.24
$6.95

Technical Indicators

Market Signals
Indicator
RBBN
FHTX
Relative Strength Index (RSI) 43.18 61.43
Support Level $2.06 $5.22
Resistance Level $2.30 $5.88
Average True Range (ATR) 0.13 0.31
MACD 0.02 -0.02
Stochastic Oscillator 35.62 99.15

Price Performance

Historical Comparison
RBBN
FHTX

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: